Anti-smoking drug passes safety review

GlaxoSmithKline's anti-smoking drug Zyban has passed a European safety review.

Anti-smoking drug passes safety review
Fri, 26 Jul, 2002 - 12:38

GlaxoSmithKline's anti-smoking drug Zyban has passed a European safety review.

But the European Agency for the Evaluation of Medicinal Products says EU authorities are expected to keep the drug under regular review.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

Benefit image

Introductory offer. Annual billed once for first year. Monthly (discount first 3 months) billed monthly, then €10/month. Ts&Cs apply.

CONNECT WITH US TODAY

WHATSAPP

NEWSLETTERS

NOTIFICATIONS

Be the first to know the latest news and updates

More in this section

empty J1 USA visa for man US visa crackdown is an assault on students' rights
Sad boy standing alone in the hallway Derval McDonagh: We cannot say what happened to Grace will not happen again 
AI chat technology, Businessman use smartphone with virtual screen of AI chatbot communicate and answer questions. Artificial in Agentic opportunity for Irish business: The time to act is now
CourtsHeathrowOrganisation: GlaxosmithklineOrganisation: European Agency for the Evaluation of Medicinal ProductsOrganisation: EUOrganisation: NHS
<p>In the first eight months of the year, 116,099 new cars were registered, a 3.4% increase, of which 20,656 were electric cars representing a 37% year-on-year increase. File picture</p>

Electric car sales surge by 70% in Ireland, but Tesla's decline continues

READ NOW

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Latest

Business

Push Notifications

By clicking on sign up you will be the first to know about a selection of business content on this browser. Please note if you are unable to sign up via your mobile web browser, download and sign up for mobile push notifications via our FREE news app.

Sign Up
IE logo
Devices


UNLIMITED ACCESS TO THE IRISH EXAMINER FOR TEAMS AND ORGANISATIONS
FIND OUT MORE

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Fergus Finlay
Fergus Finlay

Analysis

Lunchtime News

Newsletter

Keep up with stories of the day with our lunchtime news wrap and important breaking news alerts.

Most Read

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited